Telemedicine helps improve participation in clinical trials
Nemours Children's Health System researchers develop novel ways to achieve informed consent...
List view / Grid view
News
FDA approves Palynziq for PKU, a rare and serious genetic disease
Novel enzyme therapy for adults with PKU who have uncontrolled blood phenylalanine concentrations with current treatment...
NIH begins testing Ebola treatment in early-stage trial
Scientists developed monoclonal antibody from Ebola survivor...
Ingestible ‘bacteria on a chip’ could help diagnose disease
Ultra-low-power sensors carrying genetically engineered bacteria can detect gastric bleeding...
FDA approves Doptelet for thrombocytopenia in chronic liver disease
The FDA has approved Doptelet tablets to treat low blood platelet count in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure...
Agilent highlighted lab efficiency through innovative solutions at Analytica 2018
Agilent Technologies Inc. (NYSE: A) showcased its line-up of innovative solutions for laboratory efficiency at Analytica, held April 10 – 13, in Munich, Germany...
Experimental drug eases effects of gluten for coeliac patients on gluten-free diet
First proof-of-concept study shows AMG 714 (anti-IL-15 monoclonal antibody) potentially protects celiac patients from inadvertent gluten exposure
GEA and Perceptive Engineering – a partnership for the global pharmaceutical industry
GEA and Perceptive Engineering have announced a collaboration to promote and deploy cutting-edge multivariate monitoring and Advanced Process Control (APC) solutions for batch and continuous pharmaceutical process units...
Antidepressant use may be linked to increased risk of weight gain
Prolonged use of antidepressants may lead to increased risk of weight gain...
FDA approves Prolia for glucocorticoid-induced osteoporosis
The FDA has approved the use of Prolia for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at high risk of fracture...
Procedure plus medication is better than standard treatment for heart disease patients
Percutaneous coronary intervention (PCI), along with prescribed medication, is better than medication alone as initial treatment for people with the most common form of heart disease.
Winners of the Cleanroom Technology 2018 Awards announced
The winners of the Cleanroom Technology Awards 2018 have been announced. The awards have been introduced to recognise and reward achievements, celebrating the best product innovations from those exhibiting at the Cleanroom Technology Conference 2018 (16-17 May)...
DNA-based vaccine treatment for colorectal cancer to undergo first human study
Researchers hope immunotherapy will prevent against overactive immune response...
FDA approves Aimovig as a preventive treatment for migraines
The FDA has approved Aimovig for the preventive treatment of a migraine in adults. The treatment is given by once-monthly self-injections...
Eczema drug effective against severe asthma
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies...
